These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4192092)

  • 1. Amantadine in parkinsonism.
    Hunter KR; Stern GM; Laurence DR; Armitage P
    Lancet; 1970 May; 1(7657):1127-9. PubMed ID: 4192092
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Calver DM; Zilkha KJ; Knill-Jones RP
    Lancet; 1970 Feb; 1(7641):259-62. PubMed ID: 4189290
    [No Abstract]   [Full Text] [Related]  

  • 3. Amantadine therapy in parkinsonism.
    Forssman B; Kihlstrand S; Larsson LE
    Acta Neurol Scand; 1972; 48(1):1-18. PubMed ID: 4553409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amantadine therapy in Parkinsonism].
    Forssman B; Kihlstrand S; Larsson LE
    Lakartidningen; 1972 Mar; 69():55-9. PubMed ID: 4577428
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined treatment of parkinsonism with L-dopa and amantadine.
    Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
    Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
    [No Abstract]   [Full Text] [Related]  

  • 6. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
    [No Abstract]   [Full Text] [Related]  

  • 7. Amantadine for Parkinson's disease.
    Mann DC; Pearce LA; Waterbury LD
    Neurology; 1971 Sep; 21(9):958-62. PubMed ID: 4936828
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
    Mindham RH; Gaind R; Anstee BH; Rimmer L
    Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of amantadine in Parkinson's disease. Results of a double-blind trial.
    Dallos V; Heathfield K; Stone P; Allen FA
    Br Med J; 1970 Oct; 4(5726):24-6. PubMed ID: 4919119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 11. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
    Silver DE; Sahs AL
    Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
    [No Abstract]   [Full Text] [Related]  

  • 12. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 13. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study.
    Laitinen LV; Vilkki J
    Ann Clin Res; 1971 Aug; 3(4):207-11. PubMed ID: 4937341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinson's disease with amantadine].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.
    Callagham N; Mcllroy M; O'Connor M
    Ir J Med Sci; 1974 Mar; 143(2):67-78. PubMed ID: 4617744
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Parkinson's disease with amantadine and L-Dopa.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.